Hospital Pharmacy Europe - Nephrology,

Click here

Tuesday 21 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Nephrology

Magazine	Sponsored content
News	Video

Mon 15 Apr

PDUFA action date for PA21
Following the submission of the New Drug Application (NDA) for PA21, the US Food and Drug Administration (FDA) has announced that...

Tue 15 Jan

Two antihypertensive + NSAID drugs may take toll on kidneys
Physicians who prescribe a combination of two antihypertensive drugs to their patients may want to be extra vigilant if...

Tue 4 Dec
2012

Baxter expands dialysis line with $4B purchase of Gambro
Baxter International has entered into a definitive agreement to acquire Gambro, a privately held dialysis product company based...

Wed 28 Nov
2012

Exembol® for HIT now available in the UK
Mitsubishi Pharma Europe has announced the UK launch of Exembol® (argatroban), indicated for anticoagulation in adult...

Mon 5 Nov
2012

Votubia® approved in the EU
Novartis received approval from the European Commission (EC) for Votubia® (everolimus) tablets* for the treatment of adult...

Fri 21 Sep
2012

Novartis drug Votubia® recommended by CHMP
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for...

Wed 22 Aug
2012

Gore gains EU approval for vascular graft
W. L. Gore & Associates has received CE Mark for the Gore Hybrid Vascular Graft, which is designed to expand treatment...

Wed 25 Jul
2012

Chronic kidney disease: A pathway to administer intravenous iron
The chronic kidney disease population has a high incidence of iron-deficiency anaemia. This article reviews the development of an...

Mon 30 Jan
2012

Prednisone 'unnecessary' after kidney transplant
Stopping immunosuppression soon after transplantation may prevent side-effects

Wed 22 Jun
2011

New drug prevents graft rejection in kidney transplants
First-in-class biologic agent, NULOJIX® (belatacept), for kidney transplant rejection approved in EU

Tue 21 Jun
2011

New anti-kidney rejection biologic approved in EU
The European Commission has authorised a new biologic agent for prophylaxis against kidney graft rejection.

Web design, hosting and programming by ModeZero